Tag: #Global Trends

Key Development CVS Health has agreed to pay $315 million to resolve U.S. Department of Justice allegations that its pharmacies... Read more

Key Development Johnson & Johnson delivered another headline beat in Q3 2026, reporting approximately $25.4 billion in revenue, up 5.9%,... Read more

Key Development BioNTech has encountered an important test of its effort to extend mRNA technology from vaccines into oncology. In... Read more

Key Development Roche has opened another front in obesity, licensing an investigational ALK7-targeting RNA interference therapy from Rona Therapeutics in... Read more

Key Development UCB's Bimzelx became the highest-spending pharmaceutical brand in U.S. cross-platform television advertising in September 2026, with an estimated... Read more

Key Development Merck's remigromig has met the primary endpoint in the pivotal Phase 2b/3 BRUNELLO trial, validating Wnt-pathway activation as... Read more

Key Development Bristol Myers Squibb has delivered two positive Phase 3 readouts on the same day, but the programs represent... Read more

Key Development GSK plans to invest more than $800 million to transform its Upper Merion, Pennsylvania campus into an integrated... Read more

Key Development Aspen Neuroscience and Bambusa Therapeutics both filed S-1 registration statements on October 9, 2026, adding to evidence that... Read more